Iterum Therapeutics (ITRM)
undefined
undefined%
At close: undefined
2.03
2.78%
Pre-market Jan 07, 2025, 04:18 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -38.37M -44.43M -91.56M -52.01M -103.13M -77.06M -29.41M -13.46M
Depreciation & Amortization 1.75M 1.80M 2.10M 161.00K 152.00K 136.00K 65.00K n/a
Stock-Based Compensation 784.00K 4.76M 4.32M 2.76M 2.17M 1.29M 392.00K 348.00K
Other Working Capital 540.00K 416.00K -503.00K -9.88M 6.45M -2.45M -3.27M 630.00K
Other Non-Cash Items -6.26M 17.09M 8.14M 17.71M 4.15M 2.04M -95.00K -830.00K
Deferred Income Tax n/a n/a 61.60M 1.41M -125.00K -701.00K 44.00K n/a
Change in Working Capital 2.76M 2.31M -440.00K -24.56M 17.90M -1.60M -1.60M 1.82M
Operating Cash Flow -39.33M -18.47M -15.84M -54.53M -78.89M -75.89M -30.60M -11.30M
Capital Expenditures -13.00K -62.00K -61.00K -11.00K -24.00K -90.00K -812.00K n/a
Acquisitions n/a -14.02K 54.53K n/a n/a n/a n/a n/a
Purchase of Investments -41.18M -45.71M -67.03M n/a n/a -96.49M -53.27M n/a
Sales Maturities Of Investments 64.53M 59.73M 12.50M n/a 40.13M 87.92M 22.50M n/a
Other Investing Acitivies n/a 14.02K -54.53K n/a 40.13K -8.57K -30.77K n/a
Investing Cash Flow 23.34M 13.96M -54.59M -11.00K 40.10M -8.66M -31.59M n/a
Debt Repayment n/a -2.25M -6.52M -5.49M -1.03M 14.51M n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a 433.00K n/a n/a 60.00K 32.17M 45.87M 20.85M
Financial Cash Flow 1.03M -1.82M 83.13M 64.47M -974.00K 120.84M 45.87M 20.85M
Net Cash Flow -15.02M -6.38M 12.69M 9.93M -39.78M 36.19M -16.32M 9.55M
Free Cash Flow -39.34M -18.54M -15.90M -54.54M -78.91M -75.98M -31.42M -11.30M